First Header Logo Second Header Logo

Rakhee Vaidya

Concepts (86)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Primary Myelofibrosis
6
2012
6
1.710
Why?
Polycythemia Vera
1
2012
2
0.500
Why?
Benzodiazepines
1
2011
7
0.470
Why?
Monosomy
1
2011
5
0.460
Why?
Cytokines
1
2012
239
0.440
Why?
Anxiety
1
2011
155
0.420
Why?
Survivors
1
2011
155
0.400
Why?
Leukemia, Myeloid, Acute
1
2011
180
0.380
Why?
Survival Rate
6
2018
855
0.360
Why?
Lymphoma, Non-Hodgkin
2
2017
24
0.330
Why?
Disease-Free Survival
5
2018
309
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2018
443
0.290
Why?
Breast Neoplasms
1
2011
730
0.280
Why?
Aged, 80 and over
7
2018
3908
0.260
Why?
Prognosis
6
2015
1426
0.260
Why?
Karyotyping
3
2011
28
0.250
Why?
Proportional Hazards Models
4
2012
769
0.240
Why?
Adult
8
2018
8705
0.230
Why?
Middle Aged
9
2018
11519
0.220
Why?
Aged
8
2018
10010
0.200
Why?
Multivariate Analysis
2
2012
699
0.190
Why?
Gene Rearrangement
1
2018
12
0.190
Why?
Oncogene Proteins, Fusion
1
2018
17
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2018
9
0.190
Why?
Proto-Oncogene Proteins c-bcl-6
1
2018
6
0.190
Why?
Proto-Oncogene Proteins c-myc
1
2018
24
0.190
Why?
Immunoglobulins
1
2018
13
0.190
Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
32
0.190
Why?
Female
9
2018
18849
0.170
Why?
Hyperglycemia
1
2017
84
0.170
Why?
Predictive Value of Tests
3
2012
813
0.150
Why?
Humans
10
2018
29158
0.140
Why?
Male
8
2018
18549
0.140
Why?
Cytogenetic Analysis
2
2011
15
0.140
Why?
Cyclophosphamide
3
2018
35
0.130
Why?
Vincristine
3
2018
21
0.130
Why?
Etoposide
3
2018
37
0.130
Why?
Phenotype
2
2012
665
0.130
Why?
Prednisone
3
2018
51
0.130
Why?
Doxorubicin
3
2018
61
0.130
Why?
Neoplasm Recurrence, Local
2
2015
343
0.120
Why?
Case-Control Studies
2
2012
931
0.120
Why?
Medical Records
1
2011
67
0.110
Why?
Interleukin-15
1
2011
4
0.110
Why?
Receptors, Interleukin-2
1
2011
5
0.110
Why?
Protein Array Analysis
1
2011
16
0.110
Why?
Interleukin-8
1
2011
24
0.110
Why?
Interleukin-12
1
2011
26
0.110
Why?
Platelet Count
1
2010
21
0.110
Why?
Retrospective Studies
3
2018
2962
0.110
Why?
Leukemia
1
2010
44
0.110
Why?
Health Status Indicators
1
2010
75
0.110
Why?
Blood Transfusion
1
2010
70
0.110
Why?
Transplantation Conditioning
1
2009
15
0.100
Why?
Follow-Up Studies
2
2012
2175
0.100
Why?
Hematopoietic Stem Cell Transplantation
1
2009
94
0.100
Why?
Adolescent
3
2011
3176
0.090
Why?
Combined Modality Therapy
1
2009
558
0.090
Why?
Treatment Outcome
2
2015
3153
0.090
Why?
Minnesota
2
2011
17
0.060
Why?
Bone Marrow Examination
2
2011
8
0.060
Why?
United States
1
2009
3752
0.050
Why?
Chi-Square Distribution
2
2011
315
0.050
Why?
Risk Factors
3
2011
3708
0.050
Why?
B-Lymphocytes
1
2015
70
0.040
Why?
Time Factors
2
2011
2091
0.040
Why?
T-Lymphocytes
1
2015
116
0.040
Why?
Risk Assessment
2
2011
1362
0.040
Why?
Blood Glucose
1
2017
498
0.040
Why?
Young Adult
2
2011
2425
0.030
Why?
Chromosome Aberrations
1
2011
23
0.030
Why?
Janus Kinase 2
1
2011
7
0.030
Why?
Databases as Topic
1
2010
24
0.030
Why?
Hemoglobins
1
2010
43
0.030
Why?
Leukocyte Count
1
2010
59
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
160
0.030
Why?
Cell Transformation, Neoplastic
1
2010
70
0.030
Why?
Survival Analysis
1
2011
475
0.030
Why?
Up-Regulation
1
2011
205
0.030
Why?
Databases, Factual
1
2011
327
0.030
Why?
Biopsy
1
2011
251
0.030
Why?
Genotype
1
2011
839
0.020
Why?
Reproducibility of Results
1
2010
724
0.020
Why?
Mutation
1
2011
466
0.020
Why?
Age Factors
1
2010
1182
0.020
Why?
Severity of Illness Index
1
2010
900
0.020
Why?
Vaidya's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (86)
Explore
_
Co-Authors (3)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_